Alon Blankstein

FIND Neuro is developing a software-based platform that integrates and visualizes neuroimaging data to improve surgical outcomes. FIND's platform will enable the simulation of brain surgery by integrating multi-modal neuroimaging data into 3D models for surgical training, planning, and execution. The platform will interface with mixed reality displays for enhanced interaction, and clinicians will be able to use real surgical tools to virtually operate on 3D models.

EarlySense is the global leader in contact-free, continuous monitoring solutions for the healthcare continuum. EarlySense empowers clinicians to provide proactive patient care by supporting clinical teams detect opportunities for intervention.

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology. Our clinical stage product candidates include FMX101, our novel minocycline foam for the treatment of moderate-to-severe acne, FMX103 for the treatment of moderate-to-severe rosacea.

GemCyclo Bio is an early-stage bio-pharmaceutical company holding a library of novel orally available cyclic peptides targeting validated molecular pathways of immune and inflammatory diseases (I&I), Cancer, and metabolic diseases. The innovative new drugs are licensed from the Hebrew University of Jerusalem and designed and synthesized by Prof Chaim Gilon and his colleagues with the proprietary Cycloscan technology, rapidly achieving orally available small cyclic peptides which are highly potent and metabolically stable, enabling multiple routes of administration. The novel GemCyclo Bio cyclic peptides embrace the best of small molecules and of larger protein drugs; they are easy to synthesize and of low immunogenicity as small molecules, and of highest affinity and selectivity to target active site as monoclonal antibodies (mAbs), and low off-target toxicity, all at the same time in one novel cyclic peptide molecule.

SEE THE GOOD is a global data-driven campaign built to dismantle differences and create a bridge to tolerance and understanding. Leveraging the power of celebrity influence with story-telling, SEE THE GOOD highlights the achievements of individuals from marginalized cultures to change the conversation Join Michael Douglas, Emmanuelle Chriqui, David Draiman, Montana Tucker and others and SEE THE GOOD End hate based on race, colour or religion. Together we can heal the world.

FIND Neuro is developing a software-based platform that integrates and visualizes neuroimaging data to improve surgical outcomes. FIND's platform will enable the simulation of brain surgery by integrating multi-modal neuroimaging data into 3D models for surgical training, planning, and execution. The platform will interface with mixed reality displays for enhanced interaction, and clinicians will be able to use real surgical tools to virtually operate on 3D models.

Regional Distribution of Cyber Security and Networking software & hardware products, in UAE, Greece & Cyprus, Romania, Malta, Israel, Turkey, Estonia, Poland, Italy, Spain and Portugal. Value added services of Cyber Security on-premise or on the cloud for end users and re-sellers. More than 400 re-sellers in the region. Some of the vendors that we distribute with exclusivity are: Tenable, HCL, Acronis, Garland , KE-LA, Invicti, Extra-Hop, Malwarebytes, Qualys, Varonis, Druva, Bitdefender and more. Website MEA region: https://multipoint-me.com/